BACKGROUND: Mood disorders in old age increase the risk of morbidity and mortality for individuals and healthcare costs for society. Trait Neuroticism, a strong risk factor for such disorders into old age, shares common genetic variance with depression, but the more proximal biological mechanisms that mediate this connection are not well understood. Further, whether sex differences in the neural correlates of Neuroticism mirror sex differences in behavioral measures is unknown. The present research identifies sex differences in the stable neural activity associated with Neuroticism and tests whether this activity prospectively mediates Neuroticism and subsequent depressive symptoms. METHODS: A total of 100 (46 female) older participants (>55years) underwent a resting-state PET scan twice, approximately two years apart, and completed measures of Neuroticism and depressive symptoms twice. RESULTS: Replicating at both time points, Neuroticism correlated positively with resting-state regional cerebral blood-flow activity in the hippocampus and midbrain in women and the middle temporal gyrus in men. For women, hippocampal activity mediated the association between Neuroticism at baseline and depressive symptoms at follow-up. The reverse mediational model was not significant. CONCLUSIONS: Neuroticism was associated with stable neural activity in regions implicated in emotional processing and regulation for women but not men. Among women, Neuroticism prospectively predicted depressive symptoms through greater activity in the right hippocampus, suggesting one neural mechanism between Neuroticism and depression for women. Identifying responsible mechanisms for the association between Neuroticism and psychiatric disorders may help guide research on pharmacological interventions for such disorders across the lifespan.
BACKGROUND:Mood disorders in old age increase the risk of morbidity and mortality for individuals and healthcare costs for society. Trait Neuroticism, a strong risk factor for such disorders into old age, shares common genetic variance with depression, but the more proximal biological mechanisms that mediate this connection are not well understood. Further, whether sex differences in the neural correlates of Neuroticism mirror sex differences in behavioral measures is unknown. The present research identifies sex differences in the stable neural activity associated with Neuroticism and tests whether this activity prospectively mediates Neuroticism and subsequent depressive symptoms. METHODS: A total of 100 (46 female) older participants (>55years) underwent a resting-state PET scan twice, approximately two years apart, and completed measures of Neuroticism and depressive symptoms twice. RESULTS: Replicating at both time points, Neuroticism correlated positively with resting-state regional cerebral blood-flow activity in the hippocampus and midbrain in women and the middle temporal gyrus in men. For women, hippocampal activity mediated the association between Neuroticism at baseline and depressive symptoms at follow-up. The reverse mediational model was not significant. CONCLUSIONS: Neuroticism was associated with stable neural activity in regions implicated in emotional processing and regulation for women but not men. Among women, Neuroticism prospectively predicted depressive symptoms through greater activity in the right hippocampus, suggesting one neural mechanism between Neuroticism and depression for women. Identifying responsible mechanisms for the association between Neuroticism and psychiatric disorders may help guide research on pharmacological interventions for such disorders across the lifespan.
Authors: Richard J Davidson; David A Lewis; Lauren B Alloy; David G Amaral; George Bush; Jonathan D Cohen; Wayne C Drevets; Martha J Farah; Jerome Kagan; Jay L McClelland; Susan Nolen-Hoeksema; Bradley S Peterson Journal: Biol Psychiatry Date: 2002-09-15 Impact factor: 13.382
Authors: S Saxena; A L Brody; M L Ho; S Alborzian; M K Ho; K M Maidment; S C Huang; H M Wu; S C Au; L R Baxter Journal: Biol Psychiatry Date: 2001-08-01 Impact factor: 13.382
Authors: Robert T Dunn; Tim A Kimbrell; Terence A Ketter; Mark A Frye; Mark W Willis; David A Luckenbaugh; Robert M Post Journal: Biol Psychiatry Date: 2002-03-01 Impact factor: 13.382
Authors: P Videbech; B Ravnkilde; T H Pedersen; H Hartvig; A Egander; K Clemmensen; N A Rasmussen; F Andersen; A Gjedde; R Rosenberg Journal: Acta Psychiatr Scand Date: 2002-07 Impact factor: 6.392
Authors: Marjolein L Boshuisen; Gert J Ter Horst; Anne M J Paans; A A T Simone Reinders; Johan A den Boer Journal: Biol Psychiatry Date: 2002-07-15 Impact factor: 13.382
Authors: Lisa M James; Brian E Engdahl; Arthur C Leuthold; Robert F Krueger; Apostolos P Georgopoulos Journal: Exp Brain Res Date: 2015-08-30 Impact factor: 1.972
Authors: Antonio Terracciano; Monia Lobina; Maria Grazia Piras; Antonella Mulas; Alessandra Cannas; Osorio Meirelles; Angelina R Sutin; Alan B Zonderman; Manuela Uda; Laura Crisponi; David Schlessinger Journal: Psychosom Med Date: 2011-09-23 Impact factor: 4.312
Authors: Benjamin P Chapman; Ralph H Benedict; Feng Lin; Shumita Roy; Howard J Federoff; Mark Mapstone Journal: Am J Geriatr Psychiatry Date: 2017-04-03 Impact factor: 4.105
Authors: Judith Overfeld; Sonja Entringer; Jerod M Rasmussen; Christine M Heim; Martin A Styner; John H Gilmore; Pathik D Wadhwa; Claudia Buss Journal: Dev Cogn Neurosci Date: 2020-07-04 Impact factor: 6.464